Versant Venture Capital VI L.P. 13D and 13G filings for Passage Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-09 7:06 pm Sale | 2024-08-07 | 13D | Passage Bio, Inc. PASG | Versant Venture Capital VI L.P. | 0 0.000% | -4,026,417 (Position Closed) | Filing |
| 2024-05-29 4:35 pm Unchanged | 2024-05-24 | 13D | Passage Bio, Inc. PASG | Versant Venture Capital VI L.P. | 4,026,417 6.500% | 0 (Unchanged) | Filing |
| 2023-11-09 5:27 pm Unchanged | 2023-08-07 | 13D | Passage Bio, Inc. PASG | Versant Venture Capital VI L.P. | 4,026,417 7.300% | 0 (Unchanged) | Filing |
| 2020-03-13 4:52 pm Purchase | 2020-03-03 | 13D | Passage Bio, Inc. PASG | Versant Venture Capital VI L.P. | 4,026,417 9.200% | 4,026,417 (New Position) | Filing |